CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis

被引:14
作者
Jiang, Zeyong [1 ]
Zhao, Jian [2 ]
Zou, Hanlin [3 ]
Cai, Kaican [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[3] Peoples Hosp Chenghai, Shantou, Peoples R China
关键词
NSCLC; circPTPRM; miR-139-5p; SETD5; microRNA sponge; DOMAIN-CONTAINING; 5; PROGNOSTIC BIOMARKER; SPONGING MIR-139-5P; NSCLC PROGRESSION; POOR-PROGNOSIS; BREAST-CANCER; PROLIFERATION; INVASION; RNA; METASTASIS;
D O I
10.1177/15330338221090090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Circular RNAs (circRNAs) are important regulators in various cancers, especially hepatocellular carcinoma. However, the role of circ RNA PTPRM (circPTPRM) in the development of non-small-cell lung cancer (NSCLC) remains unclear. Methods: We collected 26 clinical specimens (corresponding to 26 normal lung tissues) of lung adenocarcinoma and the expression of mir-139-5p and circPTPRM were first detected. Cell proliferation was detected by EdU method, invasion/migration ability of cells was evaluated by transwell method. And the correlation between circPTPRM and mir-139-5p was detected by luciferase reporter gene and RNA pull-down assay. Finally, we verified our hypothesis with BALB/c nude mice. Results: Through bioinformatics software, we found that circPTPRM was negatively correlated with mir-139-5p, and then we used human adenocarcinoma tissue samples to further verify their relationship and get the same result. EdU method, transwell method, and luciferase assay, RNA pull-down assay were applied, and the results show that the knockdown of circPTPRM inhibit proliferation, migration, and invasion of cells can be reversed by mir-139-5p inhibitor. Next, we used Starbase v2.0 to identify the target site of miR-139-5p and focused on SET domain containing 5 (SETD5). We derive the hypothesis by verifying the relationship between miR-139-5p and SETD5 that circPTPRM may interact with miR-139-5p/SETD5 axis. At last, we evaluated the effects of circPTPRM, SETD5, and miR-139-5p on tumor growth in vivo using BALB/c nude mice to prove the hypothesis. Conclusion: We thus conclude that circPTPRM promotes the progression of NSCLC by regulating the miR-139-5p/SETD5 axis.
引用
收藏
页数:13
相关论文
共 55 条
[1]   Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer [J].
Bollu, Lakshmi Reddy ;
Mazumdar, Abhijit ;
Savage, Michelle I. ;
Brown, Powel H. .
CLINICAL CANCER RESEARCH, 2017, 23 (09) :2136-2142
[2]   Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry [J].
Bratova, Monika ;
Karlinova, Bara ;
Skrickova, Jana ;
Pesek, Milos ;
Kolek, Vitezslav ;
Koubkova, Leona ;
Hrnciarik, Michal ;
Krejci, Jana ;
Barinova, Magda ;
Havel, Libor ;
Grygarkova, Ivona ;
Brat, Kristian .
IN VIVO, 2020, 34 (01) :369-379
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[4]   Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression [J].
Cai, Xiaoyan ;
Zhao, Zheng ;
Dong, Jiangnan ;
Lv, Qiang ;
Yun, Bei ;
Liu, Jiangqi ;
Shen, Yan ;
Kang, Jie ;
Li, Jun .
CELL DEATH & DISEASE, 2019, 10 (3)
[5]   SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway [J].
Chen, Qing ;
Sun, Zhuo ;
Li, Jinfang ;
Zhang, Donghua ;
Guo, Bin ;
Zhang, Tongwen .
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2021, 40 (02) :55-63
[6]   Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer [J].
Ding, Beichen ;
Yan, Libin ;
Zhang, Yucong ;
Wang, Zhize ;
Zhang, Yangjun ;
Xia, Ding ;
Ye, Zhangqun ;
Xu, Hua .
FEBS OPEN BIO, 2019, 9 (04) :693-706
[7]   Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis [J].
Dmitriev, Alexey A. ;
Rosenberg, Eugenia E. ;
Krasnov, George S. ;
Gerashchenko, Ganna V. ;
Gordiyuk, Vasily V. ;
Pavlova, Tatiana V. ;
Kudryavtseva, Anna V. ;
Beniaminov, Artemy D. ;
Belova, Anastasia A. ;
Bondarenko, Yuriy N. ;
Danilets, Rostislav O. ;
Glukhov, Alexander I. ;
Kondratov, Aleksandr G. ;
Alexeyenko, Andrey ;
Alekseev, Boris Y. ;
Klein, George ;
Senchenko, Vera N. ;
Kashuba, Vladimir I. .
DISEASE MARKERS, 2015, 2015
[8]  
du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1136/bmjos-2020-100115]
[9]   NCCN Guidelines® Insights Non- Small Cell Lung Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines [J].
Ettinger, David S. ;
Aisner, Dara L. ;
Wood, Douglas E. ;
Akerley, Wallace ;
Bauman, Jessica ;
Chang, Joe Y. ;
Chirieac, Lucian R. ;
D'Amico, Thomas A. ;
Dilling, Thomas J. ;
Dobelbower, Michael ;
Govindan, Ramaswamy ;
Gubens, Matthew A. ;
Hennon, Mark ;
Horn, Leora ;
Lackner, Rudy P. ;
Lanuti, Michael ;
Leal, Ticiana A. ;
Lilenbaum, Rogerio ;
Lin, Jules ;
Loo, Billy W., Jr. ;
Martins, Renato ;
Otterson, Gregory A. ;
Sandip, P. ;
Reckamp, Karen ;
Riely, Gregory J. ;
Schild, Steven E. ;
Shapiro, Theresa A. ;
Stevenson, James ;
Swanson, Scott J. ;
Tauer, Kurt ;
Yang, Stephen C. ;
Gregory, Kristina ;
Hughes, Miranda .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07) :807-821
[10]   Translational genetic research of complex diseases [J].
Grouse, Lawrence .
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2015, 3 (04) :137-143